Pharmaceutical Glass Packaging Market Analysis Report By Product, By Drug Type, By Region And Segment Forecasts From 2021 To 2028

Synopsis

The global pharmaceutical glass packaging market was prized by USD 3.79 billion in 2020. It is estimated to witness an 8.8% CAGR from 2021 to 2028.

Drivers

The wide-ranging consumption of generic injectable medicines, together with the greater demand from pharmaceutical manufacturing, is expected to power the expansion of the market for pharmaceutical glass packaging.

Glass creates an obstruction to atmospheric gases, for example, oxygen and carbon dioxide, from incoming the main container, justifying the threat of contamination of the medicines. Glass wrapping reduces the medicine’s vulnerability to ruin, for example, oxidation as well as hydrolysis.

Furthermore, glass packaging assists in defending against fleeing of the volatile elements, thus raising the steadiness of the medicine. Every one of these factors is expected to increase the demand for the product, during the near future.

The increasing significance of generic medicines along with admittance to enhanced healthcare amenities are expected to present development openings to the pharmaceutical glass packaging market.

Effect of Covid-19

The progressively increasing demand for the medications along with additional healthcare amenities is the influence of the Covid-19 pandemic on pharmaceutical manufacturing. The gush in demand for pharmaceuticals, due to the pandemic, has certainly moved the market development. The demand is likely to attain a new-fangled height in the case of the endorsement for Covid-19 vaccines, build up by diverse companies and establishments in different nations.

Product Insight

In 2020, the bottles section retained the major 35.1% revenue share of the pharmaceutical glass packaging market. On the source of product, the market is segmented into cartridges, vials, ampoules, syringes, and bottles. Because of their large sustainability and greater logical performance, following ampoules, vials are anticipated to rise by the subsequent highest revenue sourced CAGR, during the forecast period.

Depending on the size, glass bottles utilized for pharmaceutical packaging are classified into specifically two types, large bottles, and small bottles. The large dimension glass bottles are utilized for the packing of transfusion, infusion, and reagents. Oral liquids and syrup bottles are packed using small glass bottles. The division of small dimension bottles is estimated to observe escalation due to the various fresh openings, together with the increasing expenditure of oral tablets, which are wrapped up in small bottles.

Ampoules section held the biggest 74.7% volume share of the market, in 2020, due to their enhanced analytical presentation and appropriateness. Ampoules which are mainly produced using glass are estimated to observe the highest enlargement during the forecast period, together in terms of quantity and revenue, due to the capability of glass to filter particular wavelengths, greater microbiological regulation, and extreme resistance to chemicals.

Drug Type Insight

The generic drug type section held a 71.2% share of global revenue and dominated the pharmaceutical glass packaging market, in 2020. Because of the rising elderly populace, increasing cases of chronic sickness along with the conclusion of medicine patents, the global market for generic drugs has observed enlargement, during the previous years.

Mainly, augmentation of the biologic drug type section is a result of the capability of biologic drugs to take care of main chronic sicknesses, particularly definite types of autoimmune sicknesses along with cancer. On the other hand, glass breaks off and delaminating which outcome from the degradation of surface are expected to reduce the development of principal glass packing, used for biological drugs.

In North America, the generic drug type section is estimated to observe superior enlargement as compared to branded drug type section, in terms of together revenue and quantity, because it is reasonably priced, while, the expirations of the patent are additionally going to direct the generic section to increase by a reasonable expansion speed. The primary glass packing is likely to observe lethargic expansion due to reduced quantity sales of branded medicines.

Regional Insight

In 2020, North America held a 36.5% revenue share and led the global pharmaceutical glass packaging market. By means of modern products direct the development, the U.S. is estimated to continue as the main driver and leading market, for the expansion of the pharmaceutical division, within the region. This enlargement is anticipated to be supported by the growth in generics, within the state, that is likely to observe constantly elevated demand, in terms of sales and volume.

During the forecast period, Asia Pacific is expected to be the highest increasing local market, on the basis of volume as well as revenue. This enlargement can be credited to the existence of many media as well as small-scale manufacturing companies, within the region. Moreover, the region has the benefit of the compassionate regulatory system that assists in backing the manufacturing companies, together with catching the attention of overseas investors.

The European region held an 18.1% share of the general quantity, in 2020. Pharmaceutical manufacturing based on research is the most important positive feature of the financial system of Europe. The manufacturing of pharmaceutical glass packaging is increasing due to the escalation in medicinal development by way of exploration, expansion, and presentation of innovative medications intended for making better the patient’s physical condition as well as the class of life, within the region.

Companies

Mostly, several manufacturing companies of pharmaceutical glass packaging are concentrated in advanced areas like North America as well as Europe. This has given rise to a deep-rooted supply chain along with manufacturing arrangements, within the states.

But, as a result of the development openings presented by these nations along with lowdown labor expenses, the companies are relocating their manufacturing plants to nations, like China, India, and Brazil. Particularly, the generic drug segment is projected to push the demand for pharmaceutical glass packaging within these nations, during the forecast period.

Some of the companies for the pharmaceutical glass packaging market are:

    • ÅžiÅŸecam Group
    • Arab Pharmaceutical Glass Co.
    • Beatson Clark
    • Gerresheimer AG
    • West Pharmaceutical Services, Inc.
    • Stölzle-Oberglas GmbH
    • Nipro Corporation
    • Owens-Illinois, Inc.
    • Piramal Enterprises Ltd.
    • Ardagh Group S.A.
    • Shandong Medicinal Glass Co., Ltd.
    • Schott AG
    • Bormioli Pharma S.r.l
    • SGD S.A.
    • Corning Incorporated

Report Scope

Segments Covered in the Report

This report forecasts revenue and volume growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2017 to 2028. For the purpose of this study, Million Insights has segmented the global pharmaceutical glass packaging market report on the basis of product, drug type, and region:

• Product Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)
    • Vials
        • Small vials
        • Large vials
    • Bottles
        • Small bottles
        • Large bottles
    • Cartridges & Syringes
    • Ampoules

• Drug Type Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)
    • Generic
    • Branded
    • Biologic

• Regional Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)
    • North America
        • U.S.
        • Canada
        • Mexico
    • Europe
        • U.K.
        • Germany
        • France
        • Italy
        • Spain
    • The Asia Pacific
        • China
        • Japan
        • India
        • South Korea
        • Australia
    • Central & South America (CSA)
        • Brazil
    • Middle East & Africa (MEA)
        • Saudi Arabia